The COVID-19 pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus-2
(SARS-CoV-2) poses an unprecedented challenge to humanity. SARS-CoV-2 infections …

Abstract The 2019 coronavirus disease (COVID-19) has become a global pandemic.
Several studies report that ABO blood group polymorphism may be related to COVID-19 …

The COVID-19 pandemic has major implications for blood transfusion. There are uncertain
patterns of demand, and transfusion institutions need to plan for reductions in donations and …

Growing evidence suggests that ABO blood group may play a role in the
immunopathogenesis of SARS‐CoV‐2 infection, with group O individuals less likely to test …

Abstract The Coronavirus Disease 2019 (COVID-19) pandemic has killed many people
worldwide since December 2019, and Iran has been among the most affected countries. In …

Iron overload is increasingly implicated as a contributor to the pathogenesis of COVID-19.
Indeed, several of the manifestations of COVID-19, such as inflammation, hypercoagulation …

Background Several articles reported the existence of an association between ABO blood
groups and COVID-19 susceptibility. Group A and group O individuals showed a higher and …

We investigated the distribution of antibodies neutralizing SARS-CoV-2 according to age,
sex or blood group in French blood donors. In 464 samples collected before the emergence …

Background COVID-19 infection is characterised, among other features, by a prothrombotic
state with high rate of venous thromboembolism (VTE), D-dimer, and fibrinogen levels …

Convalescent plasma (CP) therapy has been used since the early 1900s to treat emerging
infectious diseases; its efficacy was later associated with the evidence that polyclonal …